Global Disposable Point-Of-Care Testing (POCT) Devices Market, By Product (Glucose Monitoring Devices, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy and Fertility Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products, Cholesterol Testing Products, Others), Technology (Dipsticks, Lateral Flow Assays, Molecular Diagnostics, Microfluidics, Immunoassays, Others), Prescription Mode (Prescription-Based, OTC), End User (Hospitals, Clinics, Homecare, Research Laboratories, Ambulatory Care Centers, Others) - Industry Trends and Forecast to 2030.
Disposable Point-Of-Care Testing (POCT) Devices Market Analysis and Size
Disposable POCT devices offer ease of use and accessibility, making them suitable for various settings, including clinics, hospitals, remote areas, and even home use. They reduce the need for specialized laboratory equipment and trained personnel. Speedy test results are essential for timely decision-making in healthcare. Disposable POCT devices often provide results within minutes, enabling healthcare providers to make immediate treatment decisions and improve patient outcomes.
Data Bridge Market Research analyses that the global disposable point-of-care testing (POCT) devices market which was USD 32,960.00 million in 2022, is expected to reach USD 54,140.25 million by 2030, and is expected to undergo a CAGR of 6.4% during the forecast period of 2023 to 2030. “Cell Based” dominates the treatment segment of the global disposable point-of-care testing (POCT) devices market owing to the increasing investment in healthcare. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Disposable Point-Of-Care Testing (POCT) Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Glucose Monitoring Devices, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy and Fertility Testing Products,Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products, Cholesterol Testing Products, Others), Technology (Dipsticks, Lateral Flow Assays, Molecular Diagnostics, Microfluidics, Immunoassays, Others), Prescription Mode (Prescription-Based, OTC), End User (Hospitals, clinics, Homecare, Research Laboratories, Ambulatory Care Centers, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Danaher (U.S.), Abbott (U.S.), F. Hoffmann-La Roche Ltd.(Switzerland), BD (U.S.), Trinity Biotech Ireland (Ireland), Cardinal Health (U.S.), Thermo Fisher Scientific (U.S.), Chembio Diagnostics, Inc.(U.S.), Meridian Bioscience, Inc.(U.S.),Sekisui Diagnostics (U.S.), OraSure Technologies, Inc.(U.S.), Quidel Corporation (U.S.), Siemens Healthcare Private Limited (Germany), Nova Biomedical (U.S.), EKF Diagnostics (U.K.), Beckman Coulter, Inc.(U.S.), Chembio Diagnostics, Inc.(U.S.), Bayer AG (Germany), bioMerieux SA (France), and Johnson & Johnson Services, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Disposable point-of-care testing (POCT) devices is that encompasses the production, distribution, and utilization of disposable diagnostic testing devices designed for use at or near the point of care. These devices are used for conducting rapid diagnostic tests and delivering quick results, typically within minutes, to support healthcare professionals in making immediate treatment decisions.
Global Disposable Point-Of-Care Testing (POCT) Devices Market Dynamics
Drivers
- Increasing Disease Prevalence
The rising prevalence of chronic diseases and infectious diseases worldwide is driving the demand for rapid and accessible diagnostic solutions that can be delivered at the point of care. As diseases become more prevalent, the need for early detection and diagnosis becomes crucial. POCT devices enable healthcare providers to quickly and conveniently test patients at or near the point of care. This rapid diagnosis is essential for diseases where early intervention can significantly improve outcomes, such as infectious diseases, cardiovascular conditions, and cancer. The rise in chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders requires regular monitoring of patients' health parameters. POCT devices allow patients and healthcare professionals to monitor these conditions easily, helping to manage and control the diseases more effectively.
- Rise in Technological Advancements
Ongoing advancements in microfluidics, biosensors, and materials science have led to the development of more accurate and user-friendly disposable POCT devices, expanding their range of applications.
Opportunity
- Rising Demand for Telehealth and Remote Monitoring
The growth of telehealth and remote monitoring initiatives relies on disposable POCT devices to provide patients with the ability to perform tests at home and share results with healthcare providers. Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, rising number of market players will further expand the market's growth rate in the future.
Restraint/Challenge
- Competition from Established Diagnostics
Established diagnostic methods and centralized laboratories have a long history of reliability and trust. Convincing healthcare providers to transition to disposable POCT devices can be challenging, as they may be reluctant to abandon established testing methods. Competition encourages established diagnostics companies to invest in research and development (R&D) to create more advanced and sophisticated POCT devices. As a result, we see continuous innovation in terms of device accuracy, speed, ease of use, and the range of tests they can perform. This innovation attracts both healthcare providers and patients, driving the adoption of POCT devices. Established diagnostics companies often have extensive product portfolios that include laboratory-based diagnostic equipment and reagents. To remain competitive and capture a larger share of the market, these companies are expanding their product offerings to include POCT devices. This diversification contributes to market growth by increasing the availability of POCT options.
This global disposable point-of-care testing (POCT) devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global disposable point-of-care testing (POCT) devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In December 2018, Anteo Diagnostics of Australia collaborated with Shanghai GeneoDx Biotechnology of china introduced the AnteoBind products with an agreement of sell and distribution of product in China
- In January 2017, Chembio Diagnostics Inc, (U.S.) adopt the RVR diagnostics and expansion of the products with increased offers and availability of product in Southeast Asia
Global Disposable Point-Of-Care Testing (POCT) Devices Market Scope
The global disposable point-of-care testing (POCT) devices market is segmented on the basis of product, technology, prescription mode, and end user. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Glucose Monitoring Devices
- Cardiometabolic Monitoring Products
- Infectious Disease Testing Products
- Coagulation Monitoring Products
- Pregnancy and Fertility Testing Products
- Hematology Testing Products
- Drugs-of-Abuse Testing Products
- Fecal Occult Testing Products
- Cholesterol Testing Products
- Others
Technology
- Dipsticks
- Lateral Flow Assays
- Molecular Diagnostics
- Microfluidics
- Immunoassays
- Others
Prescription Mode
- Prescription-Based
- OTC
End User
- Hospitals
- Clinics
- Homecare
- Research Laboratories
- Ambulatory Care Centers
- Others
Global disposable Point-of-Care Testing (POCT) Devices Market Regional Analysis/Insights
Global disposable point-of-care testing (POCT) devices market is analysed, and market size insights and trends are provided by product, technology, prescription mode, and end user as referenced above.
The countries covered in the global disposable point-of-care testing (POCT) devices market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa
North America dominates the global disposable point-of-care testing (POCT) devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rising healthcare expenditure. In addition, favourable health remuneration policies, rise in chronic wounds, and a growing elderly population will further propel the market's growth rate in this region.
Asia-Pacific is expected to be the fastest-growing region in the global disposable point-of-care testing (POCT) devices market during the forecast period of 2023-2030, due to increase in the number of insurance payers in this region. Also, the development of private healthcare sector and rising awareness among the people will further propel the market's growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global disposable point-of-care testing (POCT) devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global disposable point-of-care testing (POCT) devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global disposable point-of-care testing (POCT) devices market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Disposable Point-of-Care Testing (POCT) Devices Market Share Analysis
The global disposable point-of-care testing (POCT) devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global disposable point-of-care testing (POCT) devices market.
Some of the major players operating in the global disposable point-of-care testing (POCT) devices market are:
- Danaher (U.S.)
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd.(Switzerland), BD (U.S.)
- Trinity Biotech Ireland (Ireland), Cardinal Health (U.S.)
- Thermo Fisher Scientific (U.S.)
- Chembio Diagnostics, Inc.(U.S.)
- Meridian Bioscience, Inc.(U.S.)
- Sekisui Diagnostics (U.S.)
- OraSure Technologies, Inc.(U.S.)
- Quidel Corporation (U.S.)
- Siemens Healthcare Private Limited (Germany)
- Nova Biomedical (U.S.)
- EKF Diagnostics (U.K.)
- Beckman Coulter, Inc.(U.S.)
- Chembio Diagnostics, Inc.(U.S.)
- Bayer AG (Germany)
- bioMerieux SA (France)
- Johnson & Johnson Services, Inc. (U.S.)
SKU-